nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylnaltrexone—OPRM1—autistic disorder	0.896	1	CbGaD
Methylnaltrexone—OPRM1—telencephalic ventricle—autistic disorder	0.0113	0.224	CbGeAlD
Methylnaltrexone—OPRK1—forebrain—autistic disorder	0.00416	0.0824	CbGeAlD
Methylnaltrexone—OPRM1—brainstem—autistic disorder	0.00307	0.0607	CbGeAlD
Methylnaltrexone—OPRM1—forebrain—autistic disorder	0.00296	0.0586	CbGeAlD
Methylnaltrexone—OPRM1—telencephalon—autistic disorder	0.00272	0.0539	CbGeAlD
Methylnaltrexone—OPRK1—head—autistic disorder	0.00238	0.0472	CbGeAlD
Methylnaltrexone—OPRK1—nervous system—autistic disorder	0.00226	0.0447	CbGeAlD
Methylnaltrexone—OPRK1—central nervous system—autistic disorder	0.00217	0.043	CbGeAlD
Methylnaltrexone—CYP2D6—hindbrain—autistic disorder	0.00214	0.0425	CbGeAlD
Methylnaltrexone—OPRK1—cerebellum—autistic disorder	0.00212	0.0421	CbGeAlD
Methylnaltrexone—OPRK1—brain—autistic disorder	0.00173	0.0342	CbGeAlD
Methylnaltrexone—OPRM1—head—autistic disorder	0.00169	0.0335	CbGeAlD
Methylnaltrexone—OPRM1—nervous system—autistic disorder	0.00161	0.0318	CbGeAlD
Methylnaltrexone—OPRM1—central nervous system—autistic disorder	0.00155	0.0306	CbGeAlD
Methylnaltrexone—Nalbuphine—OPRM1—autistic disorder	0.00138	0.173	CrCbGaD
Methylnaltrexone—CYP2D6—brainstem—autistic disorder	0.00123	0.0243	CbGeAlD
Methylnaltrexone—OPRM1—brain—autistic disorder	0.00123	0.0243	CbGeAlD
Methylnaltrexone—CYP2D6—forebrain—autistic disorder	0.00119	0.0235	CbGeAlD
Methylnaltrexone—Oxymorphone—OPRM1—autistic disorder	0.00112	0.141	CrCbGaD
Methylnaltrexone—Naltrexone—OPRM1—autistic disorder	0.00112	0.141	CrCbGaD
Methylnaltrexone—CYP2D6—telencephalon—autistic disorder	0.00109	0.0216	CbGeAlD
Methylnaltrexone—Hydrocodone—OPRM1—autistic disorder	0.000982	0.123	CrCbGaD
Methylnaltrexone—Oxycodone—OPRM1—autistic disorder	0.000896	0.113	CrCbGaD
Methylnaltrexone—CYP2D6—digestive system—autistic disorder	0.000832	0.0165	CbGeAlD
Methylnaltrexone—Buprenorphine—OPRM1—autistic disorder	0.000825	0.104	CrCbGaD
Methylnaltrexone—Naloxone—OPRM1—autistic disorder	0.000819	0.103	CrCbGaD
Methylnaltrexone—Hydromorphone—OPRM1—autistic disorder	0.000813	0.102	CrCbGaD
Methylnaltrexone—CYP2D6—head—autistic disorder	0.000679	0.0134	CbGeAlD
Methylnaltrexone—CYP2D6—nervous system—autistic disorder	0.000644	0.0128	CbGeAlD
Methylnaltrexone—CYP2D6—central nervous system—autistic disorder	0.00062	0.0123	CbGeAlD
Methylnaltrexone—CYP2D6—cerebellum—autistic disorder	0.000606	0.012	CbGeAlD
Methylnaltrexone—CYP2D6—brain—autistic disorder	0.000492	0.00975	CbGeAlD
Methylnaltrexone—OPRK1—Signaling by GPCR—GRM5—autistic disorder	7.34e-05	0.00162	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—VIP—autistic disorder	7.34e-05	0.00162	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—GRM8—autistic disorder	7.3e-05	0.00161	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HTR5A—autistic disorder	7.24e-05	0.00159	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—PDE4B—autistic disorder	7.21e-05	0.00159	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—OXTR—autistic disorder	7.11e-05	0.00156	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—AVPR1A—autistic disorder	7.08e-05	0.00156	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—WNT2—autistic disorder	7.07e-05	0.00156	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—SCT—autistic disorder	7.04e-05	0.00155	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—OPRM1—autistic disorder	6.98e-05	0.00154	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—POMC—autistic disorder	6.97e-05	0.00153	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—autistic disorder	6.94e-05	0.00153	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PDE4A—autistic disorder	6.86e-05	0.00151	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—GRM5—autistic disorder	6.83e-05	0.0015	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—VIP—autistic disorder	6.83e-05	0.0015	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—HRAS—autistic disorder	6.82e-05	0.0015	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—ADRB2—autistic disorder	6.76e-05	0.00149	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—GABBR1—autistic disorder	6.72e-05	0.00148	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—ADM—autistic disorder	6.72e-05	0.00148	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—OXTR—autistic disorder	6.62e-05	0.00146	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—CYP19A1—autistic disorder	6.58e-05	0.00145	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	6.56e-05	0.00144	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—SCT—autistic disorder	6.55e-05	0.00144	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PDE4B—autistic disorder	6.54e-05	0.00144	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—IL6—autistic disorder	6.53e-05	0.00144	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metapathway biotransformation—CYP19A1—autistic disorder	6.49e-05	0.00143	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—AVPR1A—autistic disorder	6.43e-05	0.00141	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NRP2—autistic disorder	6.38e-05	0.0014	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—AVP—autistic disorder	6.35e-05	0.0014	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—OPRM1—autistic disorder	6.34e-05	0.00139	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—HTR2A—autistic disorder	6.25e-05	0.00138	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—ADM—autistic disorder	6.25e-05	0.00138	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—GABBR1—autistic disorder	6.25e-05	0.00138	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—GRM5—autistic disorder	6.21e-05	0.00137	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—VIP—autistic disorder	6.21e-05	0.00137	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—HTR1B—autistic disorder	6.2e-05	0.00136	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—OXT—autistic disorder	6.2e-05	0.00136	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GABBR2—autistic disorder	6.16e-05	0.00135	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—COMT—autistic disorder	6.12e-05	0.00135	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HTR5A—autistic disorder	6.12e-05	0.00135	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—GSTP1—autistic disorder	6.09e-05	0.00134	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—PDE4B—autistic disorder	6.09e-05	0.00134	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—MAOA—autistic disorder	6.08e-05	0.00134	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metapathway biotransformation—COMT—autistic disorder	6.04e-05	0.00133	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—OXTR—autistic disorder	6.01e-05	0.00132	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metapathway biotransformation—GSTP1—autistic disorder	6.01e-05	0.00132	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—SCT—autistic disorder	5.95e-05	0.00131	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—DRD1—autistic disorder	5.76e-05	0.00127	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—GABBR1—autistic disorder	5.68e-05	0.00125	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—ADM—autistic disorder	5.68e-05	0.00125	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HTR1B—autistic disorder	5.63e-05	0.00124	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—OXT—autistic disorder	5.63e-05	0.00124	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—GSTM1—autistic disorder	5.6e-05	0.00123	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—DRD3—autistic disorder	5.58e-05	0.00123	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	5.54e-05	0.00122	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PDE4B—autistic disorder	5.53e-05	0.00122	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metapathway biotransformation—GSTM1—autistic disorder	5.52e-05	0.00121	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HTR1D—autistic disorder	5.49e-05	0.00121	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—IL5—autistic disorder	5.46e-05	0.0012	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CALCA—autistic disorder	5.39e-05	0.00119	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—HTR2A—autistic disorder	5.29e-05	0.00116	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PRLR—autistic disorder	5.28e-05	0.00116	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—OXT—autistic disorder	5.24e-05	0.00115	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—HTR1B—autistic disorder	5.24e-05	0.00115	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—INPP1—autistic disorder	5.24e-05	0.00115	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ACADSB—autistic disorder	5.24e-05	0.00115	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—DRD1—autistic disorder	5.23e-05	0.00115	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GABBR2—autistic disorder	5.2e-05	0.00114	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GRM8—autistic disorder	5.1e-05	0.00112	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—DRD3—autistic disorder	5.07e-05	0.00111	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—POMC—autistic disorder	4.99e-05	0.0011	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL5—autistic disorder	4.96e-05	0.00109	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—WNT2—autistic disorder	4.94e-05	0.00109	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CALCA—autistic disorder	4.9e-05	0.00108	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—DRD1—autistic disorder	4.87e-05	0.00107	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GHR—autistic disorder	4.87e-05	0.00107	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PDE4A—autistic disorder	4.8e-05	0.00106	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HTR1B—autistic disorder	4.76e-05	0.00105	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—OXT—autistic disorder	4.76e-05	0.00105	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—DRD3—autistic disorder	4.72e-05	0.00104	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—BTD—autistic disorder	4.67e-05	0.00103	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HTR1D—autistic disorder	4.64e-05	0.00102	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—IL5—autistic disorder	4.62e-05	0.00102	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CALCA—autistic disorder	4.56e-05	0.001	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—ADRB2—autistic disorder	4.52e-05	0.000995	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—AVPR1A—autistic disorder	4.49e-05	0.000988	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PRLR—autistic disorder	4.46e-05	0.000982	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—DRD1—autistic disorder	4.42e-05	0.000973	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GRM5—autistic disorder	4.34e-05	0.000954	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—VIP—autistic disorder	4.34e-05	0.000954	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GRM8—autistic disorder	4.31e-05	0.000949	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—DRD3—autistic disorder	4.28e-05	0.000942	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—AVP—autistic disorder	4.25e-05	0.000935	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—POMC—autistic disorder	4.22e-05	0.000929	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—OXTR—autistic disorder	4.2e-05	0.000924	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL5—autistic disorder	4.19e-05	0.000922	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—WNT2—autistic disorder	4.18e-05	0.000919	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SCT—autistic disorder	4.16e-05	0.000915	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CALCA—autistic disorder	4.14e-05	0.000911	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GHR—autistic disorder	4.11e-05	0.000905	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—ADRB2—autistic disorder	4.11e-05	0.000903	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PDE4A—autistic disorder	4.05e-05	0.000892	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—TDO2—autistic disorder	3.97e-05	0.000873	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GABBR1—autistic disorder	3.97e-05	0.000873	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ADM—autistic disorder	3.97e-05	0.000873	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—POMC—autistic disorder	3.96e-05	0.00087	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—EIF4E—autistic disorder	3.9e-05	0.000858	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PDE4B—autistic disorder	3.87e-05	0.000851	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—AVP—autistic disorder	3.86e-05	0.000849	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—ADRB2—autistic disorder	3.82e-05	0.000841	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—AVPR1A—autistic disorder	3.8e-05	0.000835	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—OPRM1—autistic disorder	3.74e-05	0.000824	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—DHCR7—autistic disorder	3.73e-05	0.000821	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—VIP—autistic disorder	3.67e-05	0.000807	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GRM5—autistic disorder	3.67e-05	0.000807	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PLA2G4A—autistic disorder	3.63e-05	0.000798	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—AVP—autistic disorder	3.59e-05	0.00079	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—OXTR—autistic disorder	3.55e-05	0.000781	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—EXT1—autistic disorder	3.54e-05	0.000778	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SLC6A8—autistic disorder	3.54e-05	0.000778	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—HTR2A—autistic disorder	3.53e-05	0.000778	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SCT—autistic disorder	3.51e-05	0.000773	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—ADRB2—autistic disorder	3.47e-05	0.000763	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GZMB—autistic disorder	3.42e-05	0.000753	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—DAO—autistic disorder	3.37e-05	0.000742	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GABBR1—autistic disorder	3.35e-05	0.000738	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ADM—autistic disorder	3.35e-05	0.000738	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—OXT—autistic disorder	3.32e-05	0.000731	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HTR1B—autistic disorder	3.32e-05	0.000731	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—EIF4E—autistic disorder	3.3e-05	0.000725	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PDE4B—autistic disorder	3.27e-05	0.000719	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—AVP—autistic disorder	3.26e-05	0.000717	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—UPB1—autistic disorder	3.24e-05	0.000712	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HTR2A—autistic disorder	3.21e-05	0.000706	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—PRKCB—autistic disorder	3.1e-05	0.000682	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TSC1—autistic disorder	3.09e-05	0.00068	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—DRD1—autistic disorder	3.09e-05	0.00068	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PLA2G4A—autistic disorder	3.06e-05	0.000674	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GSTM5—autistic disorder	3.01e-05	0.000662	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ASMT—autistic disorder	3.01e-05	0.000662	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NTRK2—autistic disorder	3.01e-05	0.000662	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—DRD3—autistic disorder	2.99e-05	0.000659	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—HTR2A—autistic disorder	2.99e-05	0.000657	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—PIK3CG—autistic disorder	2.97e-05	0.000652	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL5—autistic disorder	2.93e-05	0.000645	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GZMB—autistic disorder	2.89e-05	0.000637	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CALCA—autistic disorder	2.89e-05	0.000637	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SLC25A12—autistic disorder	2.83e-05	0.000622	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—POMC—autistic disorder	2.82e-05	0.000621	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PRKCB—autistic disorder	2.81e-05	0.000619	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HTR1B—autistic disorder	2.81e-05	0.000618	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—OXT—autistic disorder	2.81e-05	0.000618	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SLC19A1—autistic disorder	2.75e-05	0.000605	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HTR2A—autistic disorder	2.71e-05	0.000597	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PIK3CG—autistic disorder	2.69e-05	0.000592	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—PRKCB—autistic disorder	2.62e-05	0.000576	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TSC1—autistic disorder	2.61e-05	0.000575	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—DRD1—autistic disorder	2.61e-05	0.000575	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—POMC—autistic disorder	2.56e-05	0.000564	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PRL—autistic disorder	2.56e-05	0.000562	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NTRK2—autistic disorder	2.54e-05	0.000559	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—DRD3—autistic disorder	2.53e-05	0.000557	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—PIK3CG—autistic disorder	2.51e-05	0.000551	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL5—autistic disorder	2.48e-05	0.000545	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ADSL—autistic disorder	2.45e-05	0.000539	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CALCA—autistic disorder	2.45e-05	0.000538	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ADRB2—autistic disorder	2.43e-05	0.000534	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—XDH—autistic disorder	2.4e-05	0.000529	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—POMC—autistic disorder	2.39e-05	0.000525	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PRKCB—autistic disorder	2.38e-05	0.000523	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—STX1A—autistic disorder	2.36e-05	0.000519	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—NPAS2—autistic disorder	2.36e-05	0.000519	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—TCN2—autistic disorder	2.28e-05	0.000502	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—AVP—autistic disorder	2.28e-05	0.000501	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PIK3CG—autistic disorder	2.28e-05	0.000501	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IGF2—autistic disorder	2.27e-05	0.000499	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ADA—autistic disorder	2.17e-05	0.000478	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—POMC—autistic disorder	2.17e-05	0.000477	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PRL—autistic disorder	2.16e-05	0.000475	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PLA2G4A—autistic disorder	2.14e-05	0.000471	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—IL2—autistic disorder	2.09e-05	0.000459	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MEF2C—autistic disorder	2.08e-05	0.000459	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ADRB2—autistic disorder	2.05e-05	0.000451	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ITGB3—autistic disorder	2.03e-05	0.000447	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—RORA—autistic disorder	1.98e-05	0.000436	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—AVP—autistic disorder	1.93e-05	0.000424	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IGF2—autistic disorder	1.92e-05	0.000422	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HTR2A—autistic disorder	1.9e-05	0.000417	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL2—autistic disorder	1.89e-05	0.000417	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MAOB—autistic disorder	1.86e-05	0.000409	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PLA2G4A—autistic disorder	1.81e-05	0.000398	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TSC2—autistic disorder	1.8e-05	0.000396	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—IL2—autistic disorder	1.76e-05	0.000388	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—LEP—autistic disorder	1.76e-05	0.000388	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—APOE—autistic disorder	1.76e-05	0.000388	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MEF2C—autistic disorder	1.76e-05	0.000388	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—TPH2—autistic disorder	1.73e-05	0.00038	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ITGB3—autistic disorder	1.72e-05	0.000378	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—DPYD—autistic disorder	1.7e-05	0.000374	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PRKCB—autistic disorder	1.66e-05	0.000366	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HTR2A—autistic disorder	1.6e-05	0.000353	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL2—autistic disorder	1.6e-05	0.000352	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—APC—autistic disorder	1.59e-05	0.00035	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PIK3CG—autistic disorder	1.59e-05	0.00035	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CACNA1C—autistic disorder	1.58e-05	0.000348	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—EGF—autistic disorder	1.57e-05	0.000346	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TSC2—autistic disorder	1.52e-05	0.000335	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—POMC—autistic disorder	1.51e-05	0.000333	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—APOE—autistic disorder	1.49e-05	0.000328	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—LEP—autistic disorder	1.49e-05	0.000328	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IGF1—autistic disorder	1.46e-05	0.00032	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—MAPK1—autistic disorder	1.45e-05	0.000319	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—DHFR—autistic disorder	1.44e-05	0.000316	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PRKCB—autistic disorder	1.4e-05	0.000309	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SERPINE1—autistic disorder	1.38e-05	0.000304	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PIK3CG—autistic disorder	1.34e-05	0.000296	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—APC—autistic disorder	1.34e-05	0.000296	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—EGF—autistic disorder	1.33e-05	0.000292	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—POMC—autistic disorder	1.28e-05	0.000282	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IGF1—autistic disorder	1.23e-05	0.000271	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—MAPK1—autistic disorder	1.23e-05	0.00027	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SERPINE1—autistic disorder	1.17e-05	0.000257	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HRAS—autistic disorder	1.16e-05	0.000256	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP19A1—autistic disorder	1.13e-05	0.000248	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL2—autistic disorder	1.12e-05	0.000246	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL6—autistic disorder	1.11e-05	0.000245	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PTEN—autistic disorder	1.05e-05	0.000232	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—COMT—autistic disorder	1.05e-05	0.00023	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GSTP1—autistic disorder	1.04e-05	0.000229	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MAOA—autistic disorder	1.04e-05	0.000229	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CAT—autistic disorder	1.01e-05	0.000223	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HRAS—autistic disorder	9.84e-06	0.000216	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PLA2G4A—autistic disorder	9.57e-06	0.000211	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GSTM1—autistic disorder	9.57e-06	0.000211	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL2—autistic disorder	9.46e-06	0.000208	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL6—autistic disorder	9.41e-06	0.000207	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GPX1—autistic disorder	9.17e-06	0.000202	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PTEN—autistic disorder	8.9e-06	0.000196	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MAPK1—autistic disorder	8.56e-06	0.000188	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MTHFR—autistic disorder	8.46e-06	0.000186	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—APOE—autistic disorder	7.88e-06	0.000173	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MAPK1—autistic disorder	7.24e-06	0.000159	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PIK3CG—autistic disorder	7.11e-06	0.000156	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HRAS—autistic disorder	6.87e-06	0.000151	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—POMC—autistic disorder	6.77e-06	0.000149	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL6—autistic disorder	6.58e-06	0.000145	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HRAS—autistic disorder	5.81e-06	0.000128	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL6—autistic disorder	5.56e-06	0.000122	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PTGS2—autistic disorder	5.4e-06	0.000119	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PTEN—autistic disorder	4.71e-06	0.000104	CbGpPWpGaD
